Cook, H. Terence
Imperial College London
3 papers on CoChat
Most cited papers
- Verified
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
Fellström, B. C., Barratt, J., Cook, H., Coppo, R., Feehally, J., de Fijter, J. W., Floege, J., Hetzel, G., Jardine, A. G., Locatelli, F., et al. (2017) · The Lancet
Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes
Cited by 414
- Verified
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Floege, J., Barbour, S. J., Cattran, D. C., Hogan, J. J., Nachman, P. H., Tang, S. C. W., Wetzels, J. F. M., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2019) · Kidney International
Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes
Cited by 263
- Verified
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
Rovin, B. H., Barratt, J., Cook, H. T., Noronha, I. L., Reich, H. N., Suzuki, Y., Tang, S. C. W., Trimarch, H., & Floege, J. (2025) · Kidney International
Renal Diseases and GlomerulopathiesVasculitis and related conditions
Cited by 206
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free